(Press-News.org) Opening a clamshell of berries and seeing them coated in fuzzy mold is a downer. And it’s no small problem. Gray mold and other fungi, which cause fruit to rot, lead to significant economic losses and food waste. Now, researchers report in ACS’ Journal of Agricultural and Food Chemistry that compounds from sunflower crop waste prevented rotting in blueberries. They suggest the food industry could use these natural compounds to protect against postharvest diseases.
Sunflowers are cultivated around the world for their seeds and oil, but the flower stems — known as receptacles — are generally considered to be a waste product. Noting that this crop is particularly resistant to many plant diseases, Xiao-Dong Luo, Yun Zhao and colleagues decided to investigate whether its receptacles might contain chemical constituents responsible for this protective effect. They also wanted to find out if these compounds could be used to fend off fungal plant pathogens in fruit, as a way to avoid the toxicity and resistance associated with chemical fungicides.
The researchers used methanol and ethyl acetate to prepare extracts from sunflower stems. They then isolated and identified the components in these extracts, focusing on diterpenoids, which are known to have biological activity. They found 17 diterpenoids, including four previously unknown compounds. Most of the diterpenoids showed activity against gray mold. Four of the compounds — including two of the newly identified ones — were effective at destroying the plasma membrane of this fungus, causing its cells to leak and preventing it from forming biofilms. In another test, the researchers briefly wet blueberries with the receptacle extracts, then dried the fruits and injected them with mold spores. Over a period of six days, the receptacle extracts protected almost half the berries from mold growth. The scientists conclude that sunflower stem extracts could be used as a natural biocontrol agent to prevent postharvest disease in fruit.
The authors acknowledge support from the High-level Talent Promotion and Training Project of Kunming, the Project of Yunnan Characteristic Plant Screening and R&D Service CXO Platform, and the Scientific and Technological Innovation Team of Yunnan Province.
The paper’s abstract will be available on Oct. 25 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/10.1021/acs.jafc.3c05553
The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and all its people. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, eBooks and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter | Facebook | LinkedIn | Instagram
END
Sunflower extract fights fungi to keep blueberries fresh
2023-10-25
ELSE PRESS RELEASES FROM THIS DATE:
Global platform study presents results to guide care of severely ill patients with COVID-19 using routinely available drugs
2023-10-25
The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator Network, announce clinical trial results examining the use of vitamin C and simvastatin to treat severely ill patients with COVID-19.
Published today in JAMA and NEJM, and presented at the European Society of Intensive Care Medicine in Milan, the studies are part of the ongoing Randomized Embedded Multifactorial Adaptive Platform for Community Acquired Pneumonia (REMAP-CAP) trial.
Simvastatin, a widely available and inexpensive drug that is included on the WHO list of essential medicines, ...
Intravenous Vitamin C for patients hospitalized with COVID-19
2023-10-25
About The Study: In hospitalized patients with COVID-19, vitamin C had low probability of improving the primary composite outcome of organ support–free days and hospital survival in two harmonized randomized clinical trials.
Authors: Neill K. J. Adhikari, M.D.C.M., M.Sc., of the Sunnybrook Health Sciences Centre in Toronto, and Francois Lamontagne, M.D., M.Sc., of the Universite de Sherbrooke in Sherbrooke, Canada, are the corresponding authors.
To access the embargoed study: ...
Sigh ventilation in patients with trauma
2023-10-25
About The Study: In a randomized clinical trial including 524 trauma patients receiving mechanical ventilation with risk factors for developing acute respiratory distress syndrome, the addition of sigh breaths did not significantly increase ventilator-free days. Prespecified secondary outcome data suggest that sighs are well-tolerated and may improve clinical outcomes.
Authors: Richard K. Albert, M.D., of the University of Colorado, Denver, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.21739)
Editor’s Note: Please see the ...
Landiolol and organ failure in patients with septic shock
2023-10-25
About The Study: The results of this randomized clinical trial involving 126 patients do not support the use of the very short-acting beta-blocker landiolol for managing patients with tachycardia treated with norepinephrine for established septic shock.
Authors: Tony Whitehouse, M.D., of Queen Elizabeth Hospital in Birmingham, United Kingdom, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.20134)
Editor’s Note: Please ...
Convalescent plasma reduces mortality by 10% in COVID-19 patients in acute respiratory distress and on artificial respiratory assistance
2023-10-25
This is the conclusion of a multicentre study conducted by the University Hospital of Liège (CHU of Liège) in collaboration with 17 hospital intensive care departments in Belgium during the Covid-19 phases between October 2020 and March 2022.
This is the first study to look specifically at the effect of administering convalescent plasma to these patients whose vital prognosis is severely compromised. It confirms the value of this method for inducing passive immunisation in these patients.
The results are published in the leading medical journal The New England Journal of Medicine.
In a study published in The New ...
The changing face of gun ownership in the United States
2023-10-25
Learning how to shoot a handgun at a Las Vegas gun convention had never been on Jennifer Hubbert’s bucket list. But last fall, the professor of anthropology and Asian studies found herself doing just that. “Given my research, it felt like something I needed to do,” she says.
Hubbert is currently exploring a novel question regarding gun culture in the United States: “What does it mean to be a liberal gun owner?” The National Endowment for the Humanities (NEH) has recently awarded Hubbert with a grant to support her research and book project: Gun Culture 4.0: Understanding the New Demographics of ...
Dr. Anthony Fauci to be awarded 2024 Inamori Ethics Prize by Inamori International Center for Ethics and Excellence
2023-10-25
CLEVELAND, OH—The Inamori International Center for Ethics and Excellence at Case Western Reserve University will award Dr. Anthony Fauci, a physician, immunologist, and infectious disease expert, with the 2024 Inamori Ethics Prize.
“Dr. Fauci has cared not only for the nation’s health, but also the health of the world,” said Case Western Reserve President Eric W. Kaler. “As a scientist, research leader and public health advisor, his contributions to scientific discovery have truly improved lives. His leadership through one of the most challenging times in history—the COVID-19 pandemic—serves ...
New study: Pig welfare outweighs climate concerns for consumers
2023-10-25
Pork production is a societal concern on several fronts: antibiotics use, infectious disease, poor animal welfare and climate and environmental pressures. Even though the beef, coffee and chocolate industries are each major climate culprits, the world's total consumption of pork emits hundreds of millions of tons of CO2 every year.
But are you willing to fork over extra cash for a more climate-friendly pork roast? Or, are there other considerations that would increase your willingness to pay more? And if so, how much of a premium would you be willing to pay? Researchers from the University of Copenhagen’s Department of Food and Resource Economics investigated ...
Researchers induce brain activation using infrared light-controlled drugs
2023-10-25
Studying the brain remains one of the most challenging endeavors in neuroscience. Researchers have explored various methods for live imaging and stimulation of deep brain activity. One such method is multiphoton excitation using pulsed infrared (IR) light. This type of light is weakly absorbed by tissues and can penetrate through the bone and deep into organs like the brain. However, it has its limitations to produce focused images and to control cellular activity with precision. To overcome this, scientists have been exploring three-photon excitation with ultrafast pulsed IR light, to achieve ...
People with severe mental illness at 50 per cent higher risk of death following COVID-19 infection
2023-10-25
New research from King’s College London has found that in the UK people with severe mental illness were at increased risk of death from all causes following COVID-19 infection compared to those without severe mental illness.
Published in the British Journal of Psychiatry, the study investigated the extent to which having severe mental illness, which includes schizophrenia and psychosis, increased the risk of death during the first two waves of the COVID-19 pandemic.
Researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) and ESRC Centre for Society and Mental Health analysed data from over 660,000 ...